Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2015	FY 2010	2017 - 2019
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '15 Dec 31, 2015	Dec '10 Dec 31, 2010	2017 - 2019
Market Capitalization	1	1	1	2	0	0	Upgrade
Market Cap Growth	2414.32%	0.66%	-68.42%	33016.09%	-76.11%	50.00%	Upgrade
Enterprise Value	1	1	1	2	1	4	Upgrade
Last Close Price	0.00	0.00	0.00	0.00	0.00	30.00	Upgrade
PE Ratio	-	-	-	-	0.26	-	Upgrade
PS Ratio	51.92	49.32	-	-	0.02	-	Upgrade
PB Ratio	-5.98	-5.68	-28.41	-3.78	0.02	-0.08	Upgrade
P/TBV Ratio	-	-	-	-	0.02	-	Upgrade
P/FCF Ratio	-	-	-	-	4.78	-	Upgrade
P/OCF Ratio	-	-	-	-	0.14	-	Upgrade
EV/Sales Ratio	51.57	49.38	-	-	1.53	-	Upgrade
EV/EBIT Ratio	-	-	-	-	21.98	-	Upgrade
EV/FCF Ratio	-	-	-	-	484.05	-	Upgrade
Debt / Equity Ratio	-	-	-	-0.99	0.48	-2.05	Upgrade
Debt / FCF Ratio	-	-	-	-	95.12	-	Upgrade
Quick Ratio	0.04	0.04	-	-	15.27	-	Upgrade
Current Ratio	0.04	0.04	-	-	18.23	-	Upgrade
Return on Capital (ROIC)	-	-	-	-	-	-144.45%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	-	8.70%	-	Upgrade
Earnings Yield	-18.32%	-19.29%	-2.47%	-26.32%	388.17%	-1346.73%	Upgrade
FCF Yield	-	-15.16%	-	-26.14%	20.94%	-1668.03%	Upgrade
Buyback Yield / Dilution	-111403.21%	-35.22%	-	-	-42232.31%	-	Upgrade

Updated Sep 1, 2011. Source: S&P Global Market Intelligence. Standard template. Financial Sources.